ESC 365 - Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy

ESC Premium Access

Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy

Session: Controversies in cardiovascular risk assessment and prevention

Topic: Scores

Speaker: Associate Professor B. Mihaylova (Oxford, GB)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Associate Professor Borislava Mihaylova

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

0 follower

6 more presentations in this session

Increased mortality despite successful multifactorial cardiovascular risk reduction in healthy men. 40-year follow-up of the Helsinki businessmen study intervention trial

Speaker: Professor T. Strandberg (Helsinki, FI)

Added predictive value of follow-up blood-pressure measurements after alteration of therapy on cardiovascular risk in patients with hypertension

Speaker: Ms N. Jaspers (Utrecht, NL)

Optimizing outreach strategy to identify individuals at risk for diabetes and/or cardiovascular disease: a study of the Sodertalje municipality in Sweden

Speaker: Doctor B. Shahim (Stockholm, SE)

Associations between very low concentrations of LDL-Cholesterol, hsCRP and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study

Speaker: Professor M. Banach (Lodz, PL)

Sex hormone-binding globulin, aging, and cardiovascular risk

Speaker: Ms E. Aribas (Rotterdam, NL)

Access the full session

Controversies in cardiovascular risk assessment and prevention

Speakers: Associate Professor B. Mihaylova, Professor T. Strandberg, Ms N. Jaspers, Doctor B. Shahim, Professor M. Banach...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources